About CoreRx
CoreRx is a company based in Clearwater (United States) founded in 2006 was acquired by NovaQuest Capital Management in January 2021. CoreRx has raised $15 million across 4 funding rounds from investors including Florida High Tech Corridor, Signet Healthcare Partners and NovaQuest Capital Management. CoreRx has completed 1 acquisition, including Societal CDMO. CoreRx offers products and services including Drug Delivery Platforms, Particle Engineering, and Solid Dosage Forms. CoreRx operates in a competitive market with competitors including Unither, Akums, Recipharm, Jubilant Life Sciences and Windlas, among others.
- Headquarter Clearwater, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Corerx Pharma India Private Limited
- Date of Incorporation 13 May, 2021
- Jurisdiction Bangalore, Karnataka, India
-
Annual Revenue
$387.69 K (USD)170.39as on Mar 31, 2023
-
Net Profit
$86.78 K (USD)438.53as on Mar 31, 2023
-
EBITDA
$101.84 K (USD)307.24as on Mar 31, 2023
-
Total Equity Funding
$15 M (USD)
in 4 rounds
-
Latest Funding Round
$3 M (USD), Series A
Mar 21, 2019
-
Investors
Florida High Tech Corridor
& 2 more
-
Employee Count
Not available
- Investments & Acquisitions
-
Acquired by
NovaQuest Capital Management
(Jan 19, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of CoreRx
CoreRx offers a comprehensive portfolio of products and services, including Drug Delivery Platforms, Particle Engineering, and Solid Dosage Forms.
Develops and commercializes particle-based drug delivery systems
Engineers solutions for inhaled and bioavailability-enhanced drugs
Produces intermediate and modified release formulations
People of CoreRx
Unlock access to complete
Funding Insights of CoreRx
CoreRx has successfully raised a total of $15M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $3 million completed in March 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in CoreRx
CoreRx has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Florida High Tech Corridor, Signet Healthcare Partners and NovaQuest Capital Management.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
PE firm investing in North America and Europe
|
Locked | Locked | Locked | |
|
PE firm focused on life science and healthcare companies
|
Locked | Locked | Locked | |
|
The Florida High Tech Corridor is focused on regional high-tech development.
|
Locked | Locked | Locked |
Investor details for CoreRx
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by CoreRx
CoreRx has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Societal CDMO.
Investment portfolio details for CoreRx
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Provider of clinical trial, formulation development, packaging, and quality assurance services
|
Locked | Locked | 1982 | Locked |
Complete acquisition details for CoreRx
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - CoreRx
Detailed financials for CoreRx
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Corerx Comparisons
Peer comparison for CoreRx
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of CoreRx
CoreRx operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Unither, Akums, Recipharm, Jubilant Life Sciences and Windlas, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Contract development and manufacturing organization for proprietary and generic drugs
|
|
| Locked | Locked | Locked |
CDMO focusing on spectrum of dosage forms and therapeutic segments
|
|
| Locked | Locked | Locked |
Pharmaceutical development and manufacturing services are offered contractually.
|
|
| Locked | Locked | Locked |
Company offering a suite of R&D and manufacturing services for small molecules and generics
|
|
| Locked | Locked | Locked |
Biopharma regulatory affairs, quality control, and strategy services are provided.
|
Detailed competitors of CoreRx
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Corerx
Complete news archive for CoreRx
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CoreRx
CoreRx was founded in 2006 and raised its 1st funding round 7 years after it was founded.
CoreRx is headquartered in Clearwater, United States. It is registered at Clearwater, Florida, United States.
CoreRx is a funded company, having raised a total of $15M across 4 funding rounds to date.
Annual revenue of CoreRx is $387.69K as on Mar 31, 2023.
CoreRx was founded in 2006 in Clearwater, United States, as a contract development and manufacturing organization in the pharmaceutical sector. A range of cGMP-compliant services is offered, including pre-formulation, analytical development, product formulation, and clinical manufacturing. Support is provided for solid oral dosage forms, semi-solids, liquids, and API packaging. Operations focus on accelerating entry into clinical trials through certified facilities and technical services.
CoreRx's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
CoreRx offers Drug Delivery Platforms, Particle Engineering, and Solid Dosage Forms.
CoreRx has made 1 acquisition, including Societal CDMO.
CoreRx has 3 investors. Key investors include Florida High Tech Corridor, Signet Healthcare Partners, and NovaQuest Capital Management.